| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 01/21/2014 | US8633308 Compounds for preventing or treating viral infections and methods of use thereof |
| 01/21/2014 | US8633307 Dark quenchers for donor-acceptor energy transfer |
| 01/21/2014 | US8633168 Inhibitors of S-adenosyl-L-methionine decarboxylase |
| 01/21/2014 | US8632764 Directed evolution and in vivo panning of virus vectors |
| 01/16/2014 | US20140018314 Method of reducing intraocular pressure in humans |
| 01/15/2014 | CN103509074A Synthesis method of nucleoside diphosphate 6-deoxy-L-pyranose |
| 01/15/2014 | CN103509073A Citicoline sodium compound |
| 01/15/2014 | CN103509072A Preparation method of micro-powder capecitabine |
| 01/15/2014 | CN102584923B Method for extracting compounds from Chondrus ocelltus |
| 01/14/2014 | US8629266 Dendritic starch-based dextrin adhesives |
| 01/14/2014 | US8629265 Method for producing phosphate-bridged nucleoside conjugates |
| 01/14/2014 | US8628975 Methods and kits using extended rhodamine dyes |
| 01/14/2014 | CA2513672C Terminal-phosphate-labeled nucleotides and methods of use |
| 01/09/2014 | WO2014008344A1 Method of treating retroviral infections and related dosage regimes |
| 01/09/2014 | WO2014008236A1 Process for preparing diastereomerically enriched phosphoramidate derivatives of nucleoside compounds for treatment of viral infections |
| 01/09/2014 | WO2014007323A1 PRODUCTION INTERMEDIATE OF 1-[2'-DEOXY-4'-THIO-1'-β-D-RIBOFURANOSYL]-5-FLUOROURACIL AND PRODUCTION METHOD USING SAME |
| 01/09/2014 | US20140011961 Precursor compound connected to solid support for manufacturing 18f radiopharmaceutical, method for manufacturing same, and application thereof |
| 01/09/2014 | US20140011765 Novel synthesis of galactoside inhibitors |
| 01/09/2014 | US20140011764 Anti-Viral Pyrimidine Nucleoside Analogues |
| 01/09/2014 | US20140011763 1,2,3-Triazolyl Purine Derivatives |
| 01/08/2014 | EP2682397A1 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 01/08/2014 | CN103502452A Stacking nucleic acid and methods for use thereof |
| 01/08/2014 | CN103501757A External preparation for skin |
| 01/08/2014 | CN103497228A Novel synthesis of galactoside inhibitors |
| 01/08/2014 | CN103497227A Preparation method for tulathromycin intermediate |
| 01/08/2014 | CN103497191A Method for separating and purifying adenine and 6-iso-xanthosine from trichosanthes kirilowii maxim peels |
| 01/08/2014 | CN102219818B Thymidine derivates as well as preparation method and applications thereof in preparing tumor developing agents as ligand |
| 01/08/2014 | CN102212098B Novel cyclic pyrophosphate compound and preparation method thereof |
| 01/07/2014 | CA2573532C Compositions and methods for detection of hepatitis a virus nucleic acid |
| 01/03/2014 | WO2014003950A2 Selenium containing nucleosides as nutritional supplements |
| 01/02/2014 | US20140005371 Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof |
| 01/02/2014 | US20140005369 Uridine-based gadolinium complex and mri contrast agent including the same |
| 01/02/2014 | US20140005138 Ribofuranosyl Purine Compounds, Methods for Preparing the Same and Use Thereof |
| 01/02/2014 | US20140005136 Novel compounds and compositions and methods of use |
| 01/01/2014 | EP2679595A2 Di-(3-deoxy-3-1H-1,2,3-triazol-1-yl)-[beta]-D-galacto-pyranosyl)sulfane |
| 01/01/2014 | CN103484106A Four-color fluorescence labeling reversible terminal and use thereof in DNA (Deoxyribonucleic Acid) sequencing |
| 01/01/2014 | CN103483409A Synthetic method for preparing nelarabine |
| 01/01/2014 | CN103483408A Method for continuous production of 5'-nucleotide by using micro-channel reaction device |
| 01/01/2014 | CN102159580B Method for preparing 1,6:2,3-dianhydro-beta-d-mannopyranose |
| 12/31/2013 | US8618279 Synthesis of 2′,3′— and 3′,5′—cyclic phosphate mono-and oligonucleotides |
| 12/31/2013 | US8618075 Certain compounds, compositions and methods |
| 12/31/2013 | US8617814 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| 12/31/2013 | CA2567289C Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
| 12/26/2013 | US20130345162 Novel anti-viral therapeutic |
| 12/25/2013 | EP2043653B1 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof |
| 12/25/2013 | CN103476783A 1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment |
| 12/25/2013 | CN103467553A Method for efficiently extracting cAMP from jujube rind |
| 12/25/2013 | CN103467552A 8-cyclohexyl-2-fluoro-vidarabine as well as preparation method and application thereof |
| 12/25/2013 | CN103467551A Cordycepin and cordyceps polysaccharide as well as preparation method thereof |
| 12/25/2013 | CN103467550A 5-cyclohexyl uracil arabinoside, preparation method and application thereof |
| 12/25/2013 | CN103467549A Sulfur-bearing uridine anticancer drug, intermediate and synthesis method |
| 12/25/2013 | CN103467468A Vidarabine and Vidarabine analogues synthesized by air oxidation hydrazine removal method |
| 12/25/2013 | CN103463119A Sir2抑制剂 Sir2 inhibitor |
| 12/25/2013 | CN101747170B Conjugated type coenzyme Q analogue, preparation method and application thereof |
| 12/24/2013 | US8614313 Pharmaceutical compositions comprising forms of 5-azacytidine |
| 12/24/2013 | CA2662565C Process for the preparation of an (rp)-8-substituted camps |
| 12/19/2013 | US20130338096 Compositions for the Treatment or Prophylaxis of Viral Infections |
| 12/19/2013 | US20130338095 Chemosensory Receptor Ligand-Based Therapies |
| 12/19/2013 | US20130338094 Substituted pyrrolo]2,3-d]pyrimidines |
| 12/19/2013 | US20130337581 Nucleobase-functionalized conformationally restricted nucleotides and oligonucleotides for targeting nucleic acids |
| 12/18/2013 | EP2396340B1 Carba-nucleoside analogs for antiviral treatment |
| 12/18/2013 | EP2177527B1 2'-fluoro-4'-substituted nucleosides, the preparation and use |
| 12/18/2013 | EP1439187B1 O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates |
| 12/18/2013 | CN103450303A Azacitidine crystal form A and azacitidine crystal form B as well as preparation method thereof |
| 12/18/2013 | CN103450302A Preparation method of beta-thymidine |
| 12/18/2013 | CN103450301A Farnesyl thiosalicylic acid-nucleoside conjugate as well as preparation method and medical application thereof |
| 12/18/2013 | CN103450300A Mizoribine purification method |
| 12/18/2013 | CN102617681B Method for extracting concentrated S-adenosylmethionine |
| 12/18/2013 | CN102199183B C-di-GMP, analogues thereof and preparation method thereof |
| 12/18/2013 | CN102190695B Preparation method for 5'-deoxy-2',3'-diacetyl-5-fluorocytidine |
| 12/17/2013 | US8609833 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof |
| 12/17/2013 | US8609702 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use |
| 12/17/2013 | US8609631 Compositions and methods for treating cancer |
| 12/17/2013 | US8609628 Fused pentacyclic polyethers |
| 12/17/2013 | US8609339 System and method for emulsion breaking and recovery of biological elements |
| 12/12/2013 | US20130331561 Method of Preparation of Antiviral Compounds and Useful Intermediates Thereof |
| 12/12/2013 | US20130331351 Novel antibacterial compounds |
| 12/11/2013 | EP2671888A1 3',5'-cyclic nucleoside phosphate analogues |
| 12/11/2013 | EP2671565A1 External preparation for skin |
| 12/11/2013 | CN103439174A Method for extracting nucleoside in sample by taking titanium dioxide as solid phase |
| 12/11/2013 | CN103435672A Structure and synthesis of novel nucleoside phosphate prodrug containing substituted benzyl |
| 12/11/2013 | CN103435671A Supermolecule phospholipid based on nucleic acid bases, preparation method of supermolecule phospholipid and liposome |
| 12/11/2013 | CN103435670A Method for recycling inosine from inosine mother liquor |
| 12/11/2013 | CN103435669A Solvent-out crystallization method for uridine-5'-monophosphate disodium |
| 12/11/2013 | CN102127135B Preparation method of pyrimidine nucleoside compound or purine nucleoside compound |
| 12/10/2013 | US8604186 UV excitable fluorescent energy transfer dyes |
| 12/10/2013 | US8603998 Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors |
| 12/10/2013 | US8603807 Methods of making modular fusion protein expression products |
| 12/10/2013 | US8603803 Solid phase electrochemical synthesis with controlled product cleavage |
| 12/10/2013 | US8603741 Single molecule sequencing with two distinct chemistry steps |
| 12/10/2013 | CA2456906C Single nucleotide amplification and detection by polymerase |
| 12/05/2013 | WO2013178571A1 Process for the preparation of 2-deoxy-2-fluoro-2-methyl-d-ribofuranosyl nucleoside compounds |
| 12/05/2013 | US20130324709 Process for the preparation of 2-deoxy-2-fluoro-2-methyl-d-ribofuranosyl nucleoside compounds |
| 12/05/2013 | US20130324495 Uridine di- or tri-phosphate derivatives and uses thereof |
| 12/05/2013 | US20130324494 Novel pharmaceutical compounds |
| 12/05/2013 | US20130324491 Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b |
| 12/05/2013 | US20130323722 Methods for High Fidelity Production of Long Nucleic Acid Molecules |
| 12/04/2013 | EP2669292A1 Ribofuranosyl purine compound, preparation method therefor, and use thereof |
| 12/04/2013 | EP2669291A1 Modified Nucleotides Methods and Kits |
| 12/04/2013 | EP2669290A1 Nucleic Acid Chemical Modifications |